chr17-7251258-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001143775.2(CTDNEP1):āc.39C>Gā(p.Phe13Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000069 in 1,449,636 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001143775.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CTDNEP1 | NM_001143775.2 | c.39C>G | p.Phe13Leu | missense_variant | 1/8 | ENST00000574322.6 | NP_001137247.1 | |
CTDNEP1 | NM_015343.5 | c.39C>G | p.Phe13Leu | missense_variant | 2/9 | NP_056158.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CTDNEP1 | ENST00000574322.6 | c.39C>G | p.Phe13Leu | missense_variant | 1/8 | 1 | NM_001143775.2 | ENSP00000460683.1 | ||
ENSG00000262302 | ENST00000577138.1 | n.224-3915C>G | intron_variant | 3 | ENSP00000460571.1 |
Frequencies
GnomAD3 genomes Cov.: 30
GnomAD4 exome AF: 6.90e-7 AC: 1AN: 1449636Hom.: 0 Cov.: 34 AF XY: 0.00000139 AC XY: 1AN XY: 720850
GnomAD4 genome Cov.: 30
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 22, 2023 | The c.39C>G (p.F13L) alteration is located in exon 2 (coding exon 1) of the CTDNEP1 gene. This alteration results from a C to G substitution at nucleotide position 39, causing the phenylalanine (F) at amino acid position 13 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at